Lowering Copayments: Impact of Simvastatin Patent Expiration on Patient Adherence
Decreasing statin copayments because of the patent expiration of simvastatin has led to moderate increases in therapy adherence.
Relationship Between Generic and Preferred-brand Prescription Copayment Differentials and Generic Fill Rate
Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step Therapy
Verification of a Decision Analytic Model Assumption Using Real-World Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition Therapy
